• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Edwards Lifesciences Corp. (EW)

    -NYSE
    125.35 Down 3.93(3.04%) Jan 30, 4:08PM EST
    |After Hours : 131.04 Up 5.69 (4.54%) Jan 30, 6:21PM EST
    Add to Portfolio
    Prev Close:129.28
    Open:128.51
    Bid:124.69 x 200
    Ask:133.00 x 200
    1y Target Est:139.58
    Beta:0.5
    Next Earnings Date: 3-Feb-15EW Earnings announcement
    Day's Range:124.69 - 128.96
    52wk Range:63.04 - 137.19
    Volume:2,081,685
    Avg Vol (3m):886,219
    Market Cap:13.41B
    P/E (ttm):17.52
    EPS (ttm):7.15
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    EWDown 3.04%13.41B
    ICUIDown 3.04%1.28B
    MDTDown 2.21%70.28B
    STJDown 0.71%19.14B

    Key Statistics

    Forward P/E (1 yr):31.10
    P/S (ttm):6.17
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :3.39
    Quarterly EPS Est (Dec-14) :0.95
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):2.57

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products,... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback